Coding
Part:BBa_K4165156
Designed by: Salma Sobhy Sadek Group: iGEM22_CU_Egypt (2022-09-30)
Revision as of 14:52, 11 October 2022 by Esraa Elmligy (Talk | contribs)
MM2 Peptide
A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils.
Usage and Biology
The amino acid sequence of the MM2 peptide is LTPHKHHKHLHA. MM2 can reduce tau aggregates of full-length tau aggregates but not PHF* or PHF (VQIINK and VQIVYK respectively).
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab
Modeling
MM2 is modeled by AlphaFold2, ITASSER and TrRosetta, best model obtained from TrRosetta.
Figure 1.: Predicted 3D structure of Synthetic peptide MM2.
Table 1: Quality assessment parameters of MM2 model.
References
1. Malhis, M. (2021). Selection and characterization of D-enantiomeric peptides for the investigation of options for therapy and diagnosis of Alzheimer's disease . University of Bayreuth (Germany).
[edit]
Categories
Parameters
None |